A phase 1/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma

HUANG, J., J. CAMPIAN, T. DEWEES, Z. ŠKROTT, M. MISTRÍK, T. JOHANNS, G. ANSSTAS, O. BUTT, E. LEUTHARDT, G. DUNN, G. ZIPFEL, J. OSBUN, C. ABRAHAM, S. BADIYAN, K. SCHWETYE, J. CAIRNCROSS, J. RUBIN, A. KIM, M. GHEDA
A phase 1/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma. International Journal of Radiation Oncology, Biology, Physics. 2024, 120(3), 738-749, ISSN: 0360-3016, PMID: 38768767.